PetMed Express Inc.
PETS | NASDAQ
$1.58
-$0.02 (-1.25%)
Sep 22, 2026, 1:10 PM ET · Market open
Fiscal Year Period Ending | FY 2026 Mar 30, 2026 | FY 2025 Mar 30, 2025 | FY 2024 Mar 30, 2024 | FY 2023 Mar 30, 2023 | FY 2022 Mar 30, 2022 | FY 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | 179.02M | 226.97M | 274.1M | 256.58M | 273.42M | 303.58M |
Cost of Revenue | 138.19M | 157.84M | 196.38M | 185.84M | 198.08M | 219.27M |
Gross Profit | 40.83M | 69.14M | 77.71M | 71.01M | 75.34M | 84.32M |
Operating Income | -31.42M | -1.53M | -6.96M | 6.55M | 25.71M | 30.53M |
Interest Income | 511K | n/a | 511K | 450K | 335K | 314K |
Pretax Income | -57.36M | -587K | -6.27M | 7.45M | 27.07M | 30.95M |
Net Income | -57.29M | -6.27M | -7.46M | 5.14M | 21.1M | 23.92M |
Selling & General & Admin | 72.24M | 62.43M | 79.75M | 68.9M | 49.63M | 49.93M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 8.24M | 4.92M | -4.21M | n/a | 3.85M |
Operating Expenses | 72.24M | 70.67M | 84.67M | 64.68M | 49.63M | 53.79M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 1.21M |
Selling & Marketing Expenses | 21.51M | 23.78M | 24.51M | 19.42M | 18.8M | 21.64M |
Cost & Expenses | 210.44M | 228.5M | 281.06M | 250.03M | 247.71M | 273.05M |
Income Tax Expense | -73K | 5.68M | 1.19M | 2.31M | 5.97M | 7.03M |
Shares Outstanding (Basic) | 20.92M | 20.6M | 20.4M | 20.28M | 20.18M | 20.06M |
Shares Outstanding (Diluted) | 20.92M | 20.6M | 20.4M | 20.34M | 20.36M | 20.12M |
EPS (Basic) | -2.74 | -0.30 | -0.37 | 0.25 | 1.05 | 1.53 |
EPS (Diluted) | -2.74 | -0.30 | -0.37 | 0.25 | 1.04 | 1.52 |
EBITDA | -22.03M | 6.71M | 783K | 10.99M | 29.81M | 32.96M |
EBIT | -31.42M | -330K | -6.27M | 7.45M | 27.07M | 30.53M |
Depreciation & Amortization | 9.39M | 7.04M | 7.06M | 3.55M | 2.74M | 2.43M |
Add to Watchlist
Select watchlists to add or remove PETS